Smart Equity Invest

← Results dashboard

Q2 FY27 · NSE: SYRMA

Syrma Sgs Technology

Results filed 30 October 2026 · Market cap ₹31,341 crore · PE 73.8

GrowthGuidance raisedTranscript read

Revenue
+73.6%
on a year ago
EBITDA
+67.7%
on a year ago
Profit to shareholders
+87.2%
on a year ago
EBITDA margin
9.7%
−0.5 pts on last quarter

Syrma SGS delivered 73.6% YoY revenue growth in Q2 FY27 to ₹1,989.7 crore, supported by strong volume expansion across automotive, industrials, and export channels. Management revised its FY27 revenue growth guidance upward to 40%–45% (~₹7,000 crore) and reaffirmed its target to surpass $1 billion in revenue in FY28. Working capital improved sequentially to 63 days with positive operating cash flow generation of ₹120 crore in H1, though gross debt doubled to fund capex and component inventory buffers.

Syrma Sgs Technology Limited, Q2 FY27₹ crore, consolidated
Q2 FY27Q1 FY27vs previous quarterQ2 FY26vs a year ago
Revenue1,9901,589+25.2%1,146+73.6%
Operating profit (EBIT)171139+22.6%93.39+82.7%
Operating margin8.6%8.8%−18 bps8.1%+42 bps
Other income9.8715.06−34.5%8.74+12.9%
Exceptional items00–0–
Profit before exceptional items and tax165141+17.3%89.5+84.6%
Profit to shareholders124106+17.5%66.34+87.2%
Earnings per share (₹)6.085.19+17.1%3.44+76.7%

Source: Syrma Sgs Technology Limited’s filing to NSE, 30 October 2026. Operating profit is revenue less every expense except interest, so it leaves out other income and exceptional items. n.m.: not meaningful, because the earlier figure was zero or negative, or the latest one is a loss.

What stood out

  • Annual revenue guidance revised upwards to 40%–45% growth (~₹7,000 crore), with targeted $1 billion revenue in FY28
    SourceJ.S. Gujral: '...this gives us the confidence to revise our guidance upwards that we would be able to deliver 40% to 45% growth this year on an annualized basis, which would translate into around INR7,000 crores of revenue... we are confident that next year, that is FY28, we should be able to cross the $1 billion revenue mark in revenues.' (Transcript, Page 4)
  • Operating cash flow turned positive to ₹120 crore in H1 FY27 (33.7% of Op. EBITDA), improving working capital days to 63
    SourceBijay Agrawal: 'Our net working capital cycle improved to 63 days as of September '26 compared to 71 days in the previous quarter and 73 days as of September '25... net operating cash flows was approximately INR120 crores resulting into OCF to EBITDA conversion of approximately 34% for the H1.' (Transcript, Page 7; Presentation, Page 14)
  • Total open order book visibility reached ₹7,420 crore as of end-September 2026
    SourceBijay Agrawal: 'As on September end, we are carrying an overall open order book visibility position of INR7,420 crores.' (Transcript, Page 7)

Guidance

MetricGuidancePeriod
Consolidated Revenue Growth
SourceJ.S. Gujral: '...this gives us the confidence to revise our guidance upwards that we would be able to deliver 40% to 45% growth this year on an annualized basis, which would translate into around INR7,000 crores of revenue.' (Transcript, Page 4)
40% to 45% annual growth (approx. ₹7,000 crore+)FY27
Revenue Target
SourceJ.S. Gujral: '...confident that next year, that is FY28, we should be able to cross the $1 billion revenue mark in revenues.' (Transcript, Page 4)
Crossing $1 billion in revenueFY28
Full-year EBITDA Margin
SourceJ.S. Gujral: 'This half year my EBITDA margin is a tad lower than 10%. I expect the year to close at 10% to 10.5%.' (Transcript, Page 5)
10.0% to 10.5%FY27
Medium-term EBITDA Margin
SourceJ.S. Gujral: '...with my margin accretive projects coming into stream, I expect that we should be anything between 10.5% to 11% or maybe marginally better than 11%.' (Transcript, Page 5)
10.5% to 11.0% or marginally above 11%FY28
Export Revenue
SourceJ.S. Gujral: 'We expect this year that exports should cross the INR1,700 crores mark... next year it should give us a INR2,000 crores in exports.' (Transcript, Page 4)
Exceeding ₹1,700 crore (FY27) and reaching ₹2,000 crore (FY28)FY27–FY28
Net Working Capital Days
SourceJ.S. Gujral: '...on an annualized basis, we will strive and we are sort of focused on maintaining that fiscal discipline on working capital, and it could be anything between 60 to 65 days.' (Transcript, Page 13)
60 to 65 daysH2 FY27

Upward revision on revenue growth guidance from 35% previously to 40%–45% for FY27.

Tailwinds

  • Broad-based volume growth across domestic and export segments, driven by auto, consumer, and industrials
    SourceBijay Agrawal: 'Automotive sector business recorded a revenue growth of 91% year-on-year... Consumer business contributed approximately 29%... Industrial business recorded a strong growth of 86% year-on-year...' (Transcript, Page 6; Presentation, Page 8)
  • Rapid scaling of high-margin ODM segment, up 117% YoY in H1 FY27
    SourceJ.S. Gujral: '...ODM revenue in H1 FY27 is INR591 crores versus INR273 crores of the H1 previous year, which is 117% growth.' (Transcript, Page 5)
  • Export revenue rose 91% YoY in Q2 FY27 to ₹514 crore, driven by client onboarding in Europe and North America
    SourceBijay Agrawal: '...export revenue increased by 91% year-on-year to approximately INR514 crores for the quarter and INR901 crores for H1 registering a growth of 80% year-on-year for H1.' (Transcript, Page 6)
  • Internal operational efficiency gains via Automated Line Clearance / ARC systems improving line productivity
    SourceJ.S. Gujral: 'The initial results have shown a 5% to 6% OEE improvement on the lines, on the SMT lines... A 5% increase in OEE would result into 1,000 hours of additional line capacity available, which is equivalent to approximately 2 lines.' (Transcript, Page 22)

Headwinds

  • Global supply chain bottlenecks in electronic components causing delivery lead times to stretch up to 36–42 weeks
    SourceJ.S. Gujral: '...when the delivery lead times get extended to 36 weeks or 42 weeks... Even capacitors and resistors, they also have seen the delivery lead time stretch from 4 weeks to 8 weeks to 12 weeks to 16 weeks.' (Transcript, Pages 12, 23)
  • Cost-push pass-through without value-add markups diluted operating EBITDA margins
    SourceJ.S. Gujral: 'We have pass-through mechanisms with all customers, but we don't get a value-add on the cost push and that results in slight dilution in the margin profile. The absolute figure is being maintained, but the margin profile does take a small hit...' (Transcript, Page 4)
  • Gross margin contracted by 270 bps YoY in Q2 FY27 to 21.1%
    SourcePresentation financials table shows Gross Profit Margin fell from 23.8% in Q2 FY26 to 21.1% in Q2 FY27. (Presentation, Page 6)

New businesses and products

capacity expansion · Under construction; power-on and trial production expected by March–April 2027; commercial volume production targeted around September 2027

Dedicated PCB Manufacturing Facility

Expected benefit
Accretive margins with steady-state EBITDA margin of 15%–18% (17%–20% including PLI) and 1.2x–1.5x asset turnover generating ₹900–1,350 crore annual revenue at full ramp-up
Risks
Regulatory customer approvals taking 3–6 months; initial low capacity utilization (~40%)
Timeline
Trial run March/April 2027; series production start H2 FY28 (commercial start April–September 2027); full contribution in FY29
Investment
Total capex of ₹800–900 crore (over ₹200 crore spent, expecting another ₹200 crore in H2 FY27 and balance ₹400–450 crore in FY28); ~₹200 crore expected capital subsidy
SourceJ.S. Gujral & Bijay Agrawal: '...power on the equipment by March, start the trial production... September of '27, we should start the volume production... total investment towards the project could be INR800 crores to INR900 crores... EBITDA margin at a full capacity ramp-up should be within the range of 15% to 18%.' (Transcript, Pages 4, 7, 11, 15, 19)

new product · Facility construction commenced; expression of intent received from automotive customer

Camera Module Project for Automotive Sector

Expected benefit
Initial revenue potential of ₹50–100 crore scaling up to ₹400–500 crore over 5 years
Risks
Subject to automotive qualification standards and margin constraints of the auto sector
Timeline
Targeting start of production by end of FY27
Investment
Initial capex of ~₹25–30 crore
SourceJ.S. Gujral: 'The facility construction has started. We have got the expression of interest or intent from the customer for camera module for automotive application and we expect that by around end of this fiscal, we should be in a position to start production in that... capex... will be around INR30 crores.' (Transcript, Pages 11, 12, 16, 22–23)

partnership · Factory inaugurated in Bengaluru in early September 2026; currently undergoing ISO, IRIS, and RDSO certifications

Syrma SGS Elemaster Joint Venture

Expected benefit
Targeting ₹150–200 crore revenue in FY28
Risks
Regulatory and railway certification lead times before ramp-up
Timeline
FY28 ramp-up
Investment
Capex in the range of ₹40–50 crore
SourceJ.S. Gujral & Bijay Agrawal: 'On Elemaster, we commissioned the factory in September of '26... Next year, once these regulatory approvals and certifications are in place, we expect it to deliver anything between INR150 crores to INR200 crores of revenue.' (Transcript, Pages 16–18)

partnership · Agreement signed; undergoing setup and waiting for IATF 16949 automotive certification

Kaga Electronics Joint Venture

Expected benefit
Targeting ₹100–150 crore revenue in FY28, with long-term potential of ₹500–800 crore over 5 years
Risks
Time required to complete trial production and audits for automotive approvals
Timeline
Revenue contribution starting FY28
Investment
Capex around ₹30–50 crore
SourceJ.S. Gujral & Bijay Agrawal: 'On Kaga JV, we just signed-off the agreement... You can see around INR100 crores to INR150 crores... INR500 crores to INR800 crores' over 5 years. (Transcript, Pages 16, 23)

capacity expansion · Commissioned in Jodhpur (molded, extrusions, blow molding)

Syrma Johari MedTech Medical Plastics Facility

Expected benefit
High-margin revenue from internal consumption and third-party sales; supports 45%–50% annual growth for Syrma Johari (₹300 crore FY27 target)
Timeline
Immediate (commissioned in Q2/H1 FY27)
SourceJ.S. Gujral: 'We have commissioned high-grade medical plastic facility in Syrma Johari. It would be molded, extrusions and blow... That's a new facility which we have set up in Jodhpur.' (Transcript, Page 18; Press Release, Page 3)

Things to check

  • Revenue up over 60%: check for an acquisition or a weak year-ago quarter
  • Working capital borrowings jumped sharply from ₹285.5 crore in March 2026 to ₹694.7 crore in September 2026
    SourceBalance sheet and debt disclosures show Working Capital Loan increased from ₹2,855 million to ₹6,947 million, taking total debt from ₹3,531 million to ₹7,458 million. (Presentation, Pages 15, 17)
  • Inventory rose 48.7% from ₹1,061.6 crore at end-FY26 to ₹1,578.9 crore at end-H1 FY27 due to strategic buffering against elongated supply lead times
    SourceBalance sheet shows Inventories increased from ₹10,616 million to ₹15,789 million. (Presentation, Page 15; Transcript, Page 13)

How the call went

Management provided clear, comprehensive responses with quantitative breakdowns across segments, project pipelines, and capital allocation priorities.

Specific or vague
Management provided granular breakdowns across vertical growth rates, order book duration, capex outlays for individual JV projects, and expected PCB plant economics.
Candour
Management was candid regarding raw material cost-push diluting EBITDA percentages, supply-side component constraints extending lead times, and the front-loading of consumer orders in H1.
The hard questions
Directly addressed queries regarding why full-year guidance (40%–45%) implies a sequential H2 slowdown compared to 71% H1 growth, as well as the realistic profitability of the upcoming PCB business without PLI.

What analysts pressed on

  • Implied deceleration of revenue growth in H2 despite H2 seasonally being stronger.
  • Inventory buildup and working capital risks under severe global electronic component shortages.
  • Execution timelines, capital expenditure, and margin ramp-up for the new PCB project.
  • Profitability drag and startup losses from large greenfield investments in FY28/FY29.

Numbers against the story

The reported figures align well with management's narrative of high-volume organic expansion across verticals (revenue from operations grew 73.6% YoY to ₹1,989.7 crore in Q2). Screen flag check on >60% sales growth shows it is overwhelmingly organic, with recent acquisitions (Elcome and Syrma Johari) contributing ₹275 crore out of ₹3,578 crore H1 operating revenue. However, while narrative highlights fiscal discipline, the absolute gross debt more than doubled over the half year from ₹353 crore to ₹746 crore to fund elevated inventory holdings and ongoing capex.

Sources

Notes written by gemini-3.8-flash from the documents above on 15 November 2026. They summarise what the company said and can contain mistakes: check the source passage before relying on a point. Not investment advice.